Robert Wasserman

Stock Analyst at Benchmark

(3.13)
# 1,109
Out of 4,893 analysts
113
Total ratings
42.59%
Success rate
1.84%
Average return

Stocks Rated by Robert Wasserman

Bio-Techne
Jun 5, 2025
Reiterates: Buy
Price Target: $75
Current: $52.59
Upside: +42.61%
Kamada
May 15, 2025
Reiterates: Buy
Price Target: $15
Current: $7.87
Upside: +90.60%
OmniAb
May 12, 2025
Reiterates: Buy
Price Target: $6
Current: $2.20
Upside: +172.73%
Integer Holdings
Apr 25, 2025
Maintains: Buy
Price Target: $150$140
Current: $120.47
Upside: +16.21%
XOMA Royalty
Apr 17, 2025
Initiates: Buy
Price Target: $35
Current: $27.36
Upside: +27.92%
ImmunoPrecise Antibodies
Apr 1, 2025
Reiterates: Speculative Buy
Price Target: $3
Current: $1.92
Upside: +56.25%
AbCellera Biologics
Mar 3, 2025
Reiterates: Hold
Price Target: n/a
Current: $4.22
Upside: -
Halozyme Therapeutics
Feb 20, 2025
Reiterates: Buy
Price Target: $75
Current: $56.58
Upside: +32.57%
BioLife Solutions
Dec 19, 2024
Reiterates: Buy
Price Target: $30
Current: $22.29
Upside: +34.59%
Anebulo Pharmaceuticals
Nov 19, 2024
Reiterates: Speculative Buy
Price Target: $8
Current: $1.74
Upside: +359.77%
Reiterates: Speculative Buy
Price Target: $5
Current: $3.73
Upside: +34.05%
Maintains: Buy
Price Target: $8$12
Current: $7.33
Upside: +63.71%
Reiterates: Hold
Price Target: n/a
Current: $2.91
Upside: -
Reiterates: Hold
Price Target: n/a
Current: $129.82
Upside: -
Reiterates: Speculative Buy
Price Target: $12
Current: $0.31
Upside: +3,780.98%
Reiterates: Buy
Price Target: $45
Current: $41.13
Upside: +9.41%
Reiterates: Speculative Buy
Price Target: $4
Current: $3.91
Upside: +2.30%
Reiterates: Speculative Buy
Price Target: $4
Current: $0.24
Upside: +1,547.45%
Reiterates: Speculative Buy
Price Target: $75
Current: $1.99
Upside: +3,668.84%
Downgrades: Hold
Price Target: n/a
Current: $200.96
Upside: -
Initiates: Buy
Price Target: $580
Current: $419.88
Upside: +38.13%